Journal Article DZNE-2025-01219

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Alpha-synuclein deposition patterns in Alzheimer's disease: association with cortical amyloid beta and variable tau load.

 ;  ;  ;  ;  ;  ;  ;

2025
Springer Heidelberg

Acta neuropathologica 150(1), 46 () [10.1007/s00401-025-02952-w]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: Alpha-synuclein (α-syn) deposits are common in around half of the Alzheimer's disease (AD) cases. While direct and indirect protein interactions are suggested, the relationships between different protein aggregates remain poorly understood. Here, we aimed to characterize α-syn, amyloid beta (Aβ), and tau load distributions of AD patients. Protein deposits were automatically quantified with random forest pixel classifiers in immunohistochemical stains of up to 28 brain regions in 72 brains with advanced AD neuropathological change. α-syn-negative cases were distinguished from amygdala predominant, brainstem predominant, and cortical α-syn-positive cases. Relationships with age, sex, and ApoE genotype were examined. α-syn co-pathology was detected in 60% of AD cases, more frequently, although not significantly, in women. Half of these positive cases presented α-syn deposits in the cortex, around one-third predominantly in the amygdala, and the remaining cases primarily in the brainstem. A high α-syn load in the amygdala was associated with an increased cortical Aβ load. The cortical tau load was increased in the amygdala-predominant α-syn group, but decreased in the brainstem-predominant and cortical α-syn cases in comparison with α-syn-negative cases. ApoE4 was associated with higher hippocampal α-syn and cortical Aβ deposition. Younger age at death was associated with a focally higher Aβ and tau load. AD cases with cortical α-syn deposition tended to have a younger age at death. Here, we show that next to age, sex, and ApoE genotype, the α-syn distribution in AD is related to different Aβ and tau loads. This may have therapeutic relevance for identifying patients who respond to Aβ immunotherapy related to tau burden and underpin the need to define α-syn pathology and distribution in early disease stages.

Keyword(s): Humans (MeSH) ; Alzheimer Disease: pathology (MeSH) ; Alzheimer Disease: metabolism (MeSH) ; Alzheimer Disease: genetics (MeSH) ; Female (MeSH) ; Male (MeSH) ; alpha-Synuclein: metabolism (MeSH) ; tau Proteins: metabolism (MeSH) ; Amyloid beta-Peptides: metabolism (MeSH) ; Aged (MeSH) ; Aged, 80 and over (MeSH) ; Cerebral Cortex: metabolism (MeSH) ; Cerebral Cortex: pathology (MeSH) ; Middle Aged (MeSH) ; Brain: pathology (MeSH) ; Brain: metabolism (MeSH) ; Apolipoproteins E: genetics (MeSH) ; Alpha-synuclein ; Alzheimer’s disease ; Immunohistochemistry ; Lewy body disease ; Mixed pathology ; Quantitative neuropathology ; alpha-Synuclein ; tau Proteins ; Amyloid beta-Peptides ; Apolipoproteins E ; MAPT protein, human

Classification:

Contributing Institute(s):
  1. Translational Brain Research (AG Herms)
Research Program(s):
  1. 352 - Disease Mechanisms (POF4-352) (POF4-352)

Appears in the scientific report 2025
Database coverage:
Medline ; Creative Commons Attribution CC BY 4.0 ; OpenAccess ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DEAL Springer ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 10 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > M DZNE > M DZNE-AG Herms
Full Text Collection
Public records
Publications Database

 Record created 2025-10-31, last modified 2025-11-17